Skip to main content

Advertisement

Log in

Individual and Mixture Effects of Selected Pharmaceuticals and Personal Care Products on the Marine Phytoplankton Species Dunaliella tertiolecta

  • Published:
Archives of Environmental Contamination and Toxicology Aims and scope Submit manuscript

Abstract

Pharmaceuticals and personal care products (PPCPs) entering the environment may have detrimental effects on aquatic organisms. Simvastatin, clofibric acid, diclofenac, carbamazepine, fluoxetine, and triclosan represent some of the most commonly used and/or detected PPCPs in aquatic environments. This study analyzed the individual and mixture toxicity of these six PPCPs to the marine phytoplankton species Dunaliella tertiolecta using a standard 96-hour static algal bioassay protocol. All PPCPs tested had a significant effect on D. tertiolecta population cell density. However, of the six PPCPs tested, only triclosan yielded toxicity at typical environmental concentrations. The 96-hour EC50 values for triclosan, fluoxetine, simvastatin, diclofenac, and clofibric acid were 3.55 μg/L, 169.81 μg/L, 22,800 μg/L, 185,690 μg/L, and 224,180 μg/L, respectively. An EC50 value could not be determined for carbamazepine; however, the highest concentration tested (80,000 μg/L) reduced cell density by 42%. Both mixtures tested—simvastatin–clofibric acid and fluoxetine–triclosan—demonstrated additive toxicity. The presence of PPCP mixtures may decrease the toxicity threshold for phytoplankton populations. Detrimental effects on phytoplankton populations could ultimately impact nutrient cycling and food availability to higher trophic levels. The results of this study are a first step toward identifying the risk of PPCPs to estuarine organisms and may benefit environmental resource managers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Adolfsson-Erici M, Petterson M, Parkkonen J, Sturve J (2002) Triclosan, a commonly used bactericide found in human milk and in the aquatic environment in Sweden. Chemosphere 46:1485–1489

    Article  CAS  Google Scholar 

  • American Society for Testing and Materials (ASTM) (1996) Annual book of ASTM standards. Vol. 11.05, ASTM, West Conshohocken, Pennsylvania

    Google Scholar 

  • Andreozzi R, Marotta R, Pinto G, Pollio A (2002) Carbamazepine in water: persistence in the environment, ozonation treatment and preliminary assessment on algal toxicity. Water Res 36:2869–2877

    Article  CAS  Google Scholar 

  • Andreozzi R, Raffaele M, Nicklas P (2003) Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 50:1319–1330

    Article  CAS  Google Scholar 

  • Brooks BW, Foran CM, Richards SM, Weston J, Turner PK, Stanley JK, Solomon KR, Slattery M, La Point TW (2003) Aquatic ecotoxicology of fluoxetine. Toxicol Lett 142:169–183

    Article  CAS  Google Scholar 

  • Buser HR, Muller MD, Theobald N (1998) Occurrence of the pharmaceutical drug clofibric acid and the herbicide mecoprop in various Swiss lakes and in the North Sea. Environ Sci Technol 32:188–192

    Article  CAS  Google Scholar 

  • Cleuvers M (2003) Aquatic ecotoxicology of pharmaceuticals including the assessment of combination effects. Toxicol Lett 142:185–194

    Article  CAS  Google Scholar 

  • Cleuvers M (2004) Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotoxicol Environ Safety 59:309–315

    Article  CAS  Google Scholar 

  • Daughton CG, Ternes TA (1999) Pharmaceuticals and personal care products in the environment: agents of subtle change. Environ Health Perspect Suppl 107:907–938

    Article  CAS  Google Scholar 

  • Emblidge JP, DeLorenzo ME (2006) Preliminary risk assessment of the lipid regulating pharmaceutical, clofibric acid, to three estuarine species. Environ Res 100:216–226

    Article  CAS  Google Scholar 

  • Faust M, Altenburger R, Backhaus T, Blanck H, Boedeker W, Gramatica P, Hamer V, Scholze M, Vighi M, Grimme LH (2003) Joint algal toxicity of 16 dissimilarly acting chemicals is predictable by the concept of independent action. Aquat Toxicol 63:43–63

    Article  CAS  Google Scholar 

  • Fent K, Weston AA, Caminada D (2006) Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76:122–159

    Article  CAS  Google Scholar 

  • Ferrari B, Raxeus N, Giudice RL, Pollio A, Garric J (2003) Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol Environ Safety 55:359–370

    Article  CAS  Google Scholar 

  • Guillard RRL (1983) Culture of phytoplankton for feeding marine invertebrates. In: Berg CJ (ed) Culture of marine invertebrates. Hutchinson Ross Publishing Company, New York, pp 29–60

    Google Scholar 

  • Heberer T (2002) Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett 131:5–17

    Article  CAS  Google Scholar 

  • Henry TB, Kwon JW, Armbrust KL, Black MC (2004) Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia. Environ Toxicol Chem 23:2229–2233

    Article  CAS  Google Scholar 

  • Henschel KP, Wenzel A, Diedrich M, Fliedner A (1997) Environmental hazard assessment of pharmaceuticals. Reg Toxicol Pharmacol 25:220–225

    Article  CAS  Google Scholar 

  • Key P, Hoguet J, Reed L, Chung K, Fulton M (2007) Effects of the statin anti-hyperlipidemic agent simvastatin on grass shrimp, Palaemonetes pugio. Environ Toxicol (in press)

  • Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in U. S. streams, 1999–2000: a national reconnaissance. Environ Sci Technol 36:1202–1211

    Article  CAS  Google Scholar 

  • Lindstrom A, Buerge I, Poiger T, Bergqvist P, Muller M, Buser H (2002) Occurrence and environmental behavior of the bactericide triclosan and its methyl derivative in surface waters and in wastewater. Environ Sci Technol 36:2322–2329

    Article  Google Scholar 

  • Marking LL (1977) Methods for assessing additive toxicity of chemical mixtures. In: Mayer FL, Hamelink JL (eds) Aquatic toxicology and hazard evaluation, ASTM STP 634. American Society for Testing and Materials, pp 99–108

  • Marking LL (1985) Toxicity of chemical mixtures. In: Rand GM, Petrocelli SR (eds) Fundamentals of aquatic toxicology. Hemisphere Publishing Co., New York, pp 164–176

    Google Scholar 

  • Merck index: an encyclopedia of chemicals, drugs and biologicals, 13th ed. (2001) Smith A, Heckelman PE, O’Neil MA, Budavari S (eds) John Wiley & Sons, pp 2564

  • Miao XS, Metcalfe CD (2003) Determination of cholesterol-lowering statin drugs in aqueous samples using liquid chromatography–electrospray ionization tandem mass spectrometry. J Chrom A 998:133–141

    Article  CAS  Google Scholar 

  • Norberg-King TJ (1993) A linear interpolation method for sublethal toxicity: the inhibition concentration (ICP) approach. Technical report 03–93. U.S. Environmental Protection Agency, Duluth, Minnesota

    Google Scholar 

  • Orvos DR, Versteeg DJ, Inauen J, Capdevielle M, Rothenstein A, Cunningham V (2002) Aquatic toxicity of triclosan. Environ Toxicol Chem 21:1338–1349

    Article  CAS  Google Scholar 

  • Schwaiger J, Ferling H, Mallow U, Wintermayr H, Negele RD (2004) Toxic effects of the non-steroidal anti-inflammatory drug diclofenac: Part 1: histopathological alterations and bioaccumulation in rainbow trout. Aquat Toxicol 68:141–150

    Article  CAS  Google Scholar 

  • Ternes TA (1998) Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32:3245–3260

    Article  CAS  Google Scholar 

  • Weston JJ, Huggett DB, Rimoldi J, Foran CM, Stattery M (2001) Determination of fluoxetine (Prozac) and norfluoxetine in the aquatic environment. Annual Meeting of the Society of Environmental Toxicology and Chemistry, Baltimore, Maryland

    Google Scholar 

  • Wiegel S, Aulinger A, Brockmeyer R, Harms H, Loffler J, Reincke H, Schmidt R, Stachel B, von Tumpling W, Wanke A (2004) Pharmaceuticals in the river Elbe and its tributaries. Chemosphere 57:107–126

    Article  CAS  Google Scholar 

  • Zuccato E, Calamari D, Natangelo M, Fanelli R (2000) Presence of therapeutic drugs in the environment. Lancet 355:1789–1790

    Article  CAS  Google Scholar 

  • Zweiner C, Glauner T, Frimmel FH (2000) Biodegradation of pharmaceutical residues investigated by SPE-GC/ITD-MS and on-line derivation. HRC-J High Res Chromotogr 23:474–478

    Article  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Lorimar Serrano for assistance with the algal bioassays. Jessica Fleming received funding for this research from the National Science Foundation Research Experiences for Undergraduates grant DBI-0244007. The National Ocean Service (NOS) does not approve, recommend, or endorse any proprietary product or material mentioned in this publication.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marie E. DeLorenzo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

DeLorenzo, M.E., Fleming, J. Individual and Mixture Effects of Selected Pharmaceuticals and Personal Care Products on the Marine Phytoplankton Species Dunaliella tertiolecta . Arch Environ Contam Toxicol 54, 203–210 (2008). https://doi.org/10.1007/s00244-007-9032-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00244-007-9032-2

Keywords

Navigation